WTEN
FDA approves first nasal spray to treat dangerous allergic reactions
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. U.S. health officials on Friday approved a ...
RAPS
FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment
Teva Pharmaceuticals USA snagged US Food and Drug Administration (FDA) final approval for the first generic naloxone hydrochloride nasal spray known as Narcan, the agency announced on Friday. The life ...
Healio
FDA approves self-administered nasal spray for paroxysmal supraventricular tachycardia
Please provide your email address to receive an email when new articles are posted on . The FDA approved a rapid-acting nasal spray for the treatment of acute symptomatic paroxysmal supraventricular ...
Seeking Alpha
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® (naloxone ...
Nasdaq
MIST Hits A Milestone: FDA Approves First-Ever Self-Administered Nasal Spray For PSVT
(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) has received FDA approval for its first commercial product, CARDAMYST nasal spray, for the conversion of acute symptomatic episodes of paroxysmal ...
WTSP
FDA approves generic version of Flonase nasal spray
WASHINGTON (AP)-- Some people with seasonal and chronic allergies could now have a cheaper alternative to treat their symptoms.Regulators have approved the first generic version of Flonase.The Food ...
Seeking Alpha
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
Ra’anana, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announces ...
Business Insider
ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label
Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of age to receive neffy 1 mg dose - approval enables families of younger ...